Manuel Castellón Leal
Private Equity Investor chez Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Postes actifs de Manuel Castellón Leal
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
 Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Private Equity Investor | 01/01/2001 | - |
Historique de carrière de Manuel Castellón Leal
Anciens postes connus de Manuel Castellón Leal
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Traslational Cancer Drugs Pharma SL
 Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Directeur/Membre du Conseil | - | - |
Formation de Manuel Castellón Leal
| Universidad Complutense de Madrid | Undergraduate Degree |
| Instituto de Empresa SL | Graduate Degree |
Statistiques
Internationale
| Espagne | 5 |
Opérationnelle
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Finance |
Traslational Cancer Drugs Pharma SL
Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Health Technology |
- Bourse
- Insiders
- Manuel Castellón Leal
- Expérience
